CX Institutional Lowers Holdings in Cigna Group $CI

Key Points

• CX Institutional reduced its holdings in Cigna Group by 6.7% during the second quarter, now owning 19,208 shares valued at approximately $6.35 million.
• In a recent insider transaction, Nicole S. Jones sold 28,526 shares of Cigna at $300 each, reducing her position by 52.66% to about 25,648 shares.
• Cigna Group reported an EPS of $7.20 for the last quarter, surpassing estimates, and set its FY 2025 EPS guidance at 29.600.

CX Institutional decreased its holdings in Cigna Group (NYSE:CI - Free Report) by 6.7% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 19,208 shares of the health services provider's stock after selling 1,369 shares during the quarter. CX Institutional's holdings in Cigna Group were worth $6,350,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the business. Flaharty Asset Management LLC bought a new stake in shares of Cigna Group during the 1st quarter valued at about $28,000. 1248 Management LLC bought a new stake in shares of Cigna Group during the 1st quarter valued at about $29,000. Activest Wealth Management grew its stake in shares of Cigna Group by 360.0% during the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider's stock valued at $30,000 after acquiring an additional 72 shares during the period. Retirement Wealth Solutions LLC grew its stake in shares of Cigna Group by 74.1% during the 2nd quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider's stock valued at $33,000 after acquiring an additional 43 shares during the period. Finally, Saudi Central Bank purchased a new stake in Cigna Group in the 1st quarter worth approximately $36,000. Hedge funds and other institutional investors own 86.99% of the company's stock.

Insiders Place Their Bets

In other news, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider owned 25,648 shares of the company's stock, valued at approximately $7,694,400. This represents a 52.66% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.70% of the stock is currently owned by insiders.

Cigna Group Stock Performance

NYSE:CI opened at $284.06 on Friday. The stock's fifty day moving average is $292.89 and its 200 day moving average is $310.72. Cigna Group has a fifty-two week low of $256.89 and a fifty-two week high of $358.88. The firm has a market capitalization of $75.83 billion, a PE ratio of 15.51, a PEG ratio of 0.85 and a beta of 0.48. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, beating the consensus estimate of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. During the same quarter in the prior year, the firm posted $6.72 EPS. Cigna Group's quarterly revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, sell-side analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were paid a $1.51 dividend. The ex-dividend date was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a yield of 2.1%. Cigna Group's dividend payout ratio (DPR) is presently 32.97%.

Analysts Set New Price Targets

Several research analysts have weighed in on CI shares. Truist Financial set a $375.00 price target on Cigna Group in a research note on Tuesday, September 2nd. Barclays upped their price target on Cigna Group from $354.00 to $383.00 and gave the stock an "overweight" rating in a research note on Thursday, September 4th. Royal Bank Of Canada reiterated an "outperform" rating and set a $371.00 target price on shares of Cigna Group in a research report on Thursday, June 26th. Cantor Fitzgerald reiterated an "overweight" rating and set a $365.00 target price on shares of Cigna Group in a research report on Tuesday, August 26th. Finally, Deutsche Bank Aktiengesellschaft set a $415.00 target price on Cigna Group and gave the company a "buy" rating in a research report on Tuesday, August 5th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat, Cigna Group currently has an average rating of "Buy" and an average target price of $371.81.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.